Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.
about
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLERegulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunityWhen and where does inflammation begin in rheumatoid arthritis?Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease.Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritisFc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophagesAnti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.The lung may play a role in the pathogenesis of rheumatoid arthritis.Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden.Environmental and gene-environment interactions and risk of rheumatoid arthritis.Regulatory CD4+ T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients?ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis.Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.The isotype repertoire of antibodies against novel UH-RA peptides in rheumatoid arthritis.A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes.Pathway of PPAR-gamma coactivators in thermogenesis: a pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis.Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established diseaseAutoimmunity to citrullinated proteins and the initiation of rheumatoid arthritisCan rheumatoid arthritis be prevented?Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice.Autoantibodies to posttranslational modifications in rheumatoid arthritis.High prevalence of antinuclear antibodies in children with thyroid autoimmunity.The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.Defining populations at risk of rheumatoid arthritis: the first steps to prevention.Fingerprinting of anti-citrullinated protein antibodies (ACPA): specificity, isotypes and subclasses.Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients.Smoking and Air Pollution as Pro-Inflammatory Triggers for the Development of Rheumatoid Arthritis.The role of autoantibodies in the pathophysiology of rheumatoid arthritisAnti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.Structural cartilage damage attracts circulating rheumatoid arthritis synovial fibroblasts into affected joints.The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting.Cellular and molecular pathways of structural damage in rheumatoid arthritis.Association Between Serum Antibodies to Periodontal Bacteria and Rheumatoid Factor in the Third National Health and Nutrition Examination Survey.Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
P2860
Q27003201-CBDCB3F7-F087-4CD6-8FFD-626057651307Q27686770-C8A75887-BB9E-4A05-9D50-A2AA9058657DQ28085328-F18B710B-009A-4972-AA36-DC61135F73CFQ33662199-1832CA15-A4C8-461C-9C78-D7444122C0CFQ33789860-F766E0CD-631C-47F8-BD4D-700A38E8CACDQ33805043-A7FB3ED9-3CA9-41FA-BAC0-E478C2BE0F52Q34568233-916A429E-5C74-48B3-B208-7246F8174574Q35149378-93B71DF9-0A3F-408E-B679-02CC470CF28FQ35251912-84352E22-52AE-4B27-86EE-71CFDBCE4745Q35626851-5C8801C5-B227-40D8-98C0-1CE9ED3D25FCQ35747705-3B1373A2-0EE8-40CC-B3AE-B1A1668767B6Q35834431-0832260D-56CD-44FA-96D0-750CC75C7B54Q36020173-40AE4366-851F-4237-B2AC-A8CA2E8A1B50Q36110733-242FC2C0-09CE-4D14-B806-5BE66BDD32E5Q36120270-A1690F23-272C-4345-BE4C-A31FC4A906EFQ36183852-BC76D843-0478-4D45-9AC5-A0A90A3E3AB6Q36245913-2B69537A-5329-4421-9E20-E471765EB54EQ36565997-C72A8298-76D7-4110-B0BE-7FE2D23EBE12Q36976399-F15E6958-1BF9-4A4F-9CC4-8E91C7E1C6D4Q37076880-D58F74C7-E9D6-470F-AAFF-56081836DB00Q37085909-FF6769DD-7A62-4F9D-81DB-DCC69F98F6DEQ37179639-DB39B942-47BD-48DD-BCD0-7E27BF7F4C25Q37492376-506ADE61-ABE8-4371-A0A1-288F8D10DEB0Q37589108-5DD95C23-92AE-4C1B-8F43-E0062B4A5B8BQ37692338-B9BA581E-EB29-4CAA-9562-E3F92A8BCDEAQ37693939-56E61F3D-BF32-4536-B5D0-8B3DB9345AE0Q37704573-97C92FE5-0B1F-408D-B488-A3C62B74B6F6Q38206946-E4A989F2-10B6-44DF-93B6-C4DE1FECFBCBQ38220638-81EBA6DF-48E2-4030-954E-7C661DA6A98BQ38388421-33D4AD10-31C9-4F5D-8490-6AEA023E82A8Q38759315-64CB45DB-4E9C-485C-8C9D-97F63F1F377EQ38766413-BDCAD0A7-3696-4CA3-A68A-8F5F9C66A080Q38815526-B972E618-6919-408D-AE14-F1C98F56AABFQ38857820-3594BDDB-0650-44B3-8CC7-DBBD061E8B2AQ38936955-4B454E8D-7A37-46E7-8E48-C0BB8665D072Q39029106-4E641E97-8AE1-4261-AE3A-5C3D08509246Q39361224-769ABA0C-8306-4ADF-94B1-47CB5FAB01EBQ39825098-9EA3AF8A-4902-4031-AC5D-985718FCB51CQ40130278-D15704A0-CB0B-418F-8A13-C1F753213761Q40369679-E1CA823B-8513-4095-987B-59D7B4F994E7
P2860
Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@ast
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@en
type
label
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@ast
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@en
prefLabel
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@ast
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@en
P2093
P2860
P50
P356
P1476
Antibodies of IgG, IgA and IgM ...... pment of rheumatoid arthritis.
@en
P2093
Ewa Berglin
Heidi Kokkonen
Johan Rönnelid
Mohammed Mullazehi
P2860
P2888
P356
10.1186/AR3237
P577
2011-02-03T00:00:00Z
P5875
P6179
1044796444